Fadi S Dahdaleh
Overview
Explore the profile of Fadi S Dahdaleh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang J, Kakati R, Wehrle C, Naples R, Joyce D, Augustin T, et al.
J Minim Invasive Surg
. 2024 Jun;
27(2):95-108.
PMID: 38887001
Purpose: Postoperative pancreatic fistula (POPF) remains a devastating complication of pancreatoduodenectomy (PD). Minimally invasive PD (MIPD), including laparoscopic (LPD) and robotic (RPD) approaches, have comparable POPF rates to open PD...
2.
Chang J, Remulla D, Wehrle C, Woo K, Dahdaleh F, Joyce D, et al.
Ann Surg Oncol
. 2024 Jun;
31(9):6079-6087.
PMID: 38824193
Background: Immunotherapy is emerging as a promising option for certain locally advanced and metastatic cutaneous malignancies. However, the role of neoadjuvant immunotherapy (NIO) in Merkel cell carcinoma (MCC) with clinically...
3.
Kakati R, Naffouje S, Spanheimer P, Dahdaleh F
J Robot Surg
. 2024 Feb;
18(1):85.
PMID: 38386224
Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy with a minority of patients eligible for curative-intent surgical intervention. Pancreatic resections are technically demanding operations associated with considerable morbidity and...
4.
Parente A, Kamarajah S, Baia M, Tirotta F, Manzia T, Abu Hilal M, et al.
J Gastrointest Surg
. 2023 Feb;
27(4):741-749.
PMID: 36749556
Introduction: Data supporting the utilization of neoadjuvant chemotherapy (NAC) in patients receiving resection for cholangiocarcinoma (CCA) remains uncertain. We aimed to determine whether NAC followed by resection improves long-term survival...
5.
Williams M, Bhama A, Naffouje S, Kamarajah S, Becerra A, Zhang Y, et al.
J Gastrointest Surg
. 2022 Nov;
27(1):93-104.
PMID: 36357742
Objective: To evaluate how operative time interacts with outcomes among different approaches to pancreaticoduodenectomy (PD). Minimally invasive PDs (MIPD), which include laparoscopic (LPD) and robotic (RPD) approaches, are increasingly performed...
6.
Naffouje S, Kamarajah S, Denbo J, Salti G, Dahdaleh F
Ann Surg Oncol
. 2022 Aug;
29(12):7793-7803.
PMID: 35960450
Background: The effect of minimally invasive pancreaticoduodenectomy (MIPD), including laparoscopic and robotic pancreaticoduodenectomy (LPD and RPD, respectively), on compliance and time to return to intended oncologic therapy (RIOT) for pancreatic...
7.
Kamarajah S, Markar S, Phillips A, Kunene V, Fackrell D, Salti G, et al.
Eur J Surg Oncol
. 2022 Jun;
48(9):1980-1987.
PMID: 35718676
Background: The evidence assessing the additional benefits of adjuvant chemotherapy (AC) following neoadjuvant therapy (NAT; i.e. chemotherapy or chemoradiotherapy) and oesophagectomy for oesophageal adenocarcinoma (EAC) are limited. This study aimed...
8.
Dahdaleh F, Sherman S, Witmer H, Dhiman A, Rajeev R, Poli E, et al.
Am J Surg
. 2022 Jan;
224(1 Pt B):459-464.
PMID: 35090686
Background: Relapse of early-stage colon cancer (CC) after curative-intent resection occurs. We hypothesized that known risk factors for peritoneal metastases (PM) can define a high-risk state (HRS) that predicts recurrence...
9.
Kamarajah S, Al-Rawashdeh W, Parente A, Atherton P, Salti G, Dahdaleh F, et al.
Eur J Surg Oncol
. 2021 Dec;
48(6):1300-1308.
PMID: 34916085
Background: Data supporting routine use of adjuvant chemotherapy (AC) compared to no AC (noAC) for perihilar cholangiocarcinoma (hCCA) is unclear. This study aimed to determine whether AC improves long-term survival...
10.
Kamarajah S, Al-Rawashdeh W, White S, Abu Hilal M, Salti G, Dahdaleh F
Eur J Surg Oncol
. 2021 Sep;
48(2):425-434.
PMID: 34518052
Background: Data supporting routine use of adjuvant radiotherapy (RT) compared to without RT (noRT) for gallbladder cancer (GBC) is unclear. This study aimed to determine whether RT improves long-term survival...